KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $55.0 billion.

  • Novartis Ag's Goodwill & Intangibles rose 640.01% to $55.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $55.0 billion, marking a year-over-year increase of 640.01%. This contributed to the annual value of $55.0 billion for FY2025, which is 640.01% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Goodwill & Intangibles is $55.0 billion, which was up 640.01% from $54.6 billion recorded in Q3 2025.
  • Novartis Ag's 5-year Goodwill & Intangibles high stood at $99.0 billion for Q4 2022, and its period low was $235.0 million during Q1 2021.
  • Its 5-year average for Goodwill & Intangibles is $54.6 billion, with a median of $54.7 billion in 2025.
  • Per our database at Business Quant, Novartis Ag's Goodwill & Intangibles plummeted by 9766.73% in 2021 and then skyrocketed by 285843.66% in 2023.
  • Quarter analysis of 5 years shows Novartis Ag's Goodwill & Intangibles stood at $97.8 billion in 2021, then grew by 1.21% to $99.0 billion in 2022, then decreased by 17.5% to $81.7 billion in 2023, then plummeted by 36.72% to $51.7 billion in 2024, then increased by 6.4% to $55.0 billion in 2025.
  • Its last three reported values are $55.0 billion in Q4 2025, $54.6 billion for Q3 2025, and $54.8 billion during Q2 2025.